These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19820956)

  • 1. The morbid anatomy of dementia in Parkinson's disease.
    Kalaitzakis ME; Pearce RK
    Acta Neuropathol; 2009 Nov; 118(5):587-98. PubMed ID: 19820956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
    Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
    Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies.
    Kalaitzakis ME; Pearce RK; Gentleman SM
    Neurosci Lett; 2009 Sep; 461(1):12-5. PubMed ID: 19523504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of α-synuclein, amyloid-β and tau pathologies in Parkinson's disease progression and related dementia.
    Compta Y; Parkkinen L; Kempster P; Selikhova M; Lashley T; Holton JL; Lees AJ; Revesz T
    Neurodegener Dis; 2014; 13(2-3):154-6. PubMed ID: 24028925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease.
    Kalaitzakis ME; Christian LM; Moran LB; Graeber MB; Pearce RK; Gentleman SM
    Parkinsonism Relat Disord; 2009 Mar; 15(3):196-204. PubMed ID: 18602855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218.
    Jellinger KA
    Exp Neurol; 2011 Jan; 227(1):13-8. PubMed ID: 20965169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed sleep in Parkinson's disease: anatomical and pathological correlates.
    Kalaitzakis ME; Gentleman SM; Pearce RK
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):644-53. PubMed ID: 23363035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
    Compta Y; Parkkinen L; O'Sullivan SS; Vandrovcova J; Holton JL; Collins C; Lashley T; Kallis C; Williams DR; de Silva R; Lees AJ; Revesz T
    Brain; 2011 May; 134(Pt 5):1493-1505. PubMed ID: 21596773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faster disease progression in Parkinson's disease with type 2 diabetes is not associated with increased α-synuclein, tau, amyloid-β or vascular pathology.
    de Pablo-Fernández E; Courtney R; Rockliffe A; Gentleman S; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1080-1091. PubMed ID: 33969516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
    Cong C; Zhang W; Qian X; Qiu W; Ma C
    J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal beta-amyloid deposition in Parkinson disease with dementia.
    Kalaitzakis ME; Graeber MB; Gentleman SM; Pearce RK
    J Neuropathol Exp Neurol; 2008 Feb; 67(2):155-61. PubMed ID: 18219254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies.
    Smith C; Malek N; Grosset K; Cullen B; Gentleman S; Grosset DG
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1234-1243. PubMed ID: 31444276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.
    Irwin DJ; Lee VM; Trojanowski JQ
    Nat Rev Neurosci; 2013 Sep; 14(9):626-36. PubMed ID: 23900411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β and τ biomarkers in Parkinson's disease-dementia.
    Buongiorno M; Compta Y; Martí MJ
    J Neurol Sci; 2011 Nov; 310(1-2):25-30. PubMed ID: 21764078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.
    Wills J; Jones J; Haggerty T; Duka V; Joyce JN; Sidhu A
    Exp Neurol; 2010 Sep; 225(1):210-8. PubMed ID: 20599975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia.
    Compta Y; Ibarretxe-Bilbao N; Pereira JB; Junqué C; Bargalló N; Tolosa E; Valldeoriola F; Muñoz E; Camara A; Buongiorno M; Martí MJ
    Parkinsonism Relat Disord; 2012 Sep; 18(8):941-7. PubMed ID: 22595621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.